Applied DNA Sciences, Inc. Appoints Ray Kelly to Strategic Advisory Board
January 24, 2017 at 05:30 am EST
Share
Applied DNA Sciences, Inc. appointed Ray Kelly to its strategic advisory board, effective January 2017. Mr. Kelly, currently vice chairman of K2Intelligence, provides valuable insight into the design and development of tailored enterprise risk solutions and investigates internal and external risks affecting the safety of client assets and the reputation and stability of their key stakeholders. He was the longest-serving Commissioner of the New York City Police Department in its history and the first person to hold the post for two non-consecutive tenures. As a member of Applied DNA's SAB, Mr. Kelly will help advance the company's expansion in law enforcement and security sectors and solution offerings, working along with other distinguished industry experts. Mr. Kelly formerly worked at Cushman & Wakefield, as president of the firm's Risk Management Services group.
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Companyâs proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Companyâs Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
APPLIED DNA SCIENCES, INC. 
